St. Joseph Cancer Center - Clinical Trials: Melanoma
  

High Risk:

  • None currently

Merkel Cell:

  • None currently

Stage II/III:

  • SWOG E1697: Phase III Randomized Study of Four Weeks of High Dose IFN-alpha2b in Stage T3-T4 or N1 (microscopic) Melanoma

Advanced/Stage IV:

  • None currently

Metastatic:

  • None currently

For more information on the above clinical trials: Cheryl Patz, RN, OCN, CCRC, 360.715.4133

 

Return to previous page

Cancer Services